Oral Session 3-12A Genomic Mutation in AML

[OS3-12A-3] Analysis of mechanisms underlying clonal evolution of AML by a new single-cell sequencing platform

Ryosaku Inagaki^1,2,3, Masahiro Nakagawa^1,2, Yasuhito Nanya¹, Xingxing Qi¹, Lanying Zhao¹, June Takeda¹, Akinori Yoda¹, Ayana Kon¹, Hisashi Tsurumi⁴, Hideki Makishima¹, Seishi Ogawa^1,5,6 (1.Department of Pathology and Tumor Biology, Kyoto Univ., Kyoto, Japan, 2.DSK Project, Medical Innovation Center, Kyoto University, Kyoto, Japan, 3.Sumitomo Dainippon Pharma Co., Ltd., Osaka, Japan, 4.Department of Hematology, Gifu Univ., Gifu, Japan, 5.WPI-ASHBi, Kyoto Univ., Kyoto, Japan, 6.Centre for Hematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sweden)